.png)
iCAD is a market leader in breast cancer detection solutions built on AI that enable radiologists to find cancers earlier while improving reading workflow. iCAD’s products include ProFound AI, a high-performing, concurrent-read workflow solution built on deep-learning AI that analyzes each tomosynthesis image to detect malignant soft tissue densities and calcifications with unrivaled accuracy, and PowerLook Density Assessment, which assists radiologists in determining the patient’s breast density category. This powerful platform also includes ProFound AI Risk, the first commercially available clinical decision support tool that provides highly accurate short-term risk estimation that is truly personalized for each woman. www.icadmed.com